| Literature DB >> 33875594 |
Xinwen Lin1,2,3, Trix Twelkmeyer1,4,5, Danming Zhu6, Li Zhang7, Yang Zhao6, Chao Zhang6, Yoichiro Iwakura8, Guangxun Meng1,2,9, Zhaolin Hua6,9, Bingyu Yan7, William J Liu10, Zhongguang Luo11, Sitang Gong4, Hairong Chen6, Shuran Li12, Baidong Hou12,9, Hong Tang13,2,3,5.
Abstract
Hepatitis B virus (HBV) vaccines are composed of surface antigen HBsAg that spontaneously assembles into subviral particles. Factors that impede its humoral immunity in 5% to 10% of vaccinees remain elusive. Here, we showed that the low-level interleukin-1 receptor antagonist (IL-1Ra) can predict antibody protection both in mice and humans. Mechanistically, murine IL-1Ra-inhibited T follicular helper (Tfh) cell expansion and subsequent germinal center (GC)-dependent humoral immunity, resulting in significantly weakened protection against the HBV challenge. Compared to soluble antigens, HBsAg particle antigen displayed a unique capture/uptake and innate immune activation, including IL-1Ra expression, preferably of medullary sinus macrophages. In humans, a unique polymorphism in the RelA/p65 binding site of IL-1Ra enhancer associated IL-1Ra levels with ethnicity-dependent vaccination outcome. Therefore, the differential IL-1Ra response to particle antigens probably creates a suppressive milieu for Tfh/GC development, and neutralization of IL-1Ra would resurrect antibody response in HBV vaccine nonresponders.Entities:
Keywords: GC; IL-1Ra; Tfh; medullary sinus macrophage; particle antigens
Mesh:
Substances:
Year: 2021 PMID: 33875594 PMCID: PMC8092388 DOI: 10.1073/pnas.2019798118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205